Showing results (91-100 of 204) with videos related to

Sort By:
Pageof 21
The International Journal of Biological Markers|October 1, 1992
Endocrine effects of human recombinant interleukin-3 in cancer patientsP Lissoni, F Rovelli, E Tisi, et al.
The International Journal of Biological Markers|July 1, 1988
Serum levels of melatonin in cancer patients and their relation to body sizesS Barni, P Lissoni, S Crispino, et al.
The International Journal of Biological Markers|January 1, 1990
Lack of changes in soluble interleukin-2 receptor serum levels during chemotherapy-induced lymphocyte damageC Archili, P Lissoni, G Cattaneo, et al.
Giornale Italiano Di Cardiologia|January 1, 1976
[Use of atrial pacing in diagnosis of coronary insufficiency. Comparison between coronarography and exercise test (author's transl)]C De Ponti, G Gibelli, G Sozzi, et al.
Giornale Italiano Di Cardiologia|January 1, 1977
[Effectiveness of nifedipine on exercise tolerance in patients with angina pectoris. Comparison with a nitroderivative and a beta-blocking agent]C De Ponti, F Mauri, F Fiorista, et al.
The International Journal of Biological Markers|April 1, 1988
Neuroimmunomodulation in cancer patients: correlations between melatonin and beta-endorphin blood levels and T helper/suppressor ratioS Barni, P Lissoni, S Crispino, et al.
Minerva Pediatrica|October 1, 1992
[Niemann-Pick disease type C in monozygotic twins]L Orecchia, G Signorile, A Pezzano, et al.
Spinal Cord|January 25, 2012
Heart adaptations to long-term aerobic training in paraplegic subjects: an echocardiographic studyM A Maggioni, M Ferratini, A Pezzano, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Increase in soluble interleukin-2 receptor and neopterin serum levels during immunotherapy of cancer with interleukin-2P Lissoni, E Tisi, F Brivio, et al.
Journal of Biological Regulators and Homeostatic Agents|July 1, 1997
Anticancer neuroimmunomodulation by pineal hormones other than melatonin: preliminary phase II study of the pineal indole 5-methoxytryptophol in association with low-dose IL-2 and melatoninP Lissoni, L Fumagalli, F Paolorossi, et al.
Pageof 21